ACELYRIN (SLRN) reiterated its confidence that the proposed combination with Alumis (ALMS) is the best path forward and the most value-maximizing outcome for all ACELYRIN stockholders. Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the independent transaction committee, said, “The ACELYRIN Board and management team are confident that the proposed merger with Alumis represents the most value-maximizing path forward for our company’s stockholders. The agreement with Alumis follows a comprehensive and competitive process facilitated by the ACELYRIN Board. Furthermore, it reflects successful efforts by our Board to negotiate a revised agreement with a meaningful increase in ACELYRIN stockholders’ ownership in the combined company. With the Special Meeting just weeks away, we urge ACELYRIN stockholders to vote FOR the proposed merger with Alumis to protect the value of your investment.” The ACELYRIN Board’s disinterested and independent directors unanimously recommend that stockholders vote “FOR” the merger with Alumis. .

Protect Your Portfolio Against Market Uncertainty

Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on SLRN:

Disclaimer & DisclosureReport an Issue

ACELYRIN, INC. Amends Merger Agreement with Alumis Alumis and Acelyrin sign ammended merger agreement SLRN Earnings this Week: How Will it Perform? Acelyrin adopts limited-duration stockholder rights plan Acelyrin says Concentra indication not expected to result in superior proposal

View Comments